{"words": ["due", "complexity", "alzheimer", "disease", "multiple", "cellular", "types", "need", "targeted", "simultaneously", "order", "given", "therapy", "demonstrate", "major", "effectiveness", "coated", "microbubbles", "targeted", "lipid", "nanoemulsion", "available", "versatile", "small", "molecule", "drug", "targeting", "multiple", "pathways", "alzheimer", "disease", "pathogenesis", "known", "incorporating", "drug", "targeted", "microbubble", "lcm", "nd", "nanoemulsion", "type", "one", "obtains", "multitasking", "combination", "therapeutic", "translational", "medicine", "multitasking", "therapeutic", "targets", "scavenger", "receptors", "mainly", "class", "b", "type", "making", "possible", "various", "cell", "types", "simultaneously", "searched", "localized", "drug", "treatment", "vivo", "besides", "targeting", "proposed", "combination", "therapeutic", "include", "characteristic", "microbubble", "lcm", "subpopulation", "stable", "lcm", "suspension", "microbubbles", "well", "known", "substantially", "reduce", "acoustic", "power", "levels", "needed", "accomplishing", "temporary", "noninvasive", "transcranial", "ultrasound", "treatment", "sonoporation", "additionally", "desired", "alzheimer", "patient"], "authors": [["D'Arrigo", "Joseph S", "JS", "Cavitation-Control Technology Inc., Farmington, CT 06032, USA. Electronic address: cavcon@ntplx.net."]], "title": "Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium.", "year": null, "sentences": ["Due to the complexity of Alzheimer's disease, multiple cellular types need to be targeted simultaneously in order for a given therapy to demonstrate any major effectiveness.", "Ultrasound-sensitive coated microbubbles (in a targeted lipid nanoemulsion) are available.", "Versatile small molecule drug(s) targeting multiple pathways of Alzheimer's disease pathogenesis are known.", "By incorporating such drug(s) into the targeted \"lipid-coated microbubble\" [LCM]/\"nanoparticle-derived\" [ND] (or LCM/ND) nanoemulsion type, one obtains a multitasking combination therapeutic for translational medicine.", "This multitasking therapeutic targets cell-surface scavenger receptors (mainly class B type I), or SR-BI, making possible for various Alzheimer's-related cell types to be simultaneously searched out for localized drug treatment in vivo.", "Besides targeting cell-surface SR-BI, the proposed LCM/ND-nanoemulsion combination therapeutic(s) include a characteristic lipid-coated microbubble [LCM] subpopulation (i.e., a stable LCM suspension); such film-stabilized microbubbles are well known to substantially reduce the acoustic power levels needed for accomplishing temporary noninvasive (transcranial) ultrasound treatment, or sonoporation, if additionally desired for the Alzheimer's patient."], "id": "29274774", "text": "Due to the complexity of Alzheimer's disease, multiple cellular types need to be targeted simultaneously in order for a given therapy to demonstrate any major effectiveness. Ultrasound-sensitive coated microbubbles (in a targeted lipid nanoemulsion) are available. Versatile small molecule drug(s) targeting multiple pathways of Alzheimer's disease pathogenesis are known. By incorporating such drug(s) into the targeted \"lipid-coated microbubble\" [LCM]/\"nanoparticle-derived\" [ND] (or LCM/ND) nanoemulsion type, one obtains a multitasking combination therapeutic for translational medicine. This multitasking therapeutic targets cell-surface scavenger receptors (mainly class B type I), or SR-BI, making possible for various Alzheimer's-related cell types to be simultaneously searched out for localized drug treatment in vivo. Besides targeting cell-surface SR-BI, the proposed LCM/ND-nanoemulsion combination therapeutic(s) include a characteristic lipid-coated microbubble [LCM] subpopulation (i.e., a stable LCM suspension); such film-stabilized microbubbles are well known to substantially reduce the acoustic power levels needed for accomplishing temporary noninvasive (transcranial) ultrasound treatment, or sonoporation, if additionally desired for the Alzheimer's patient.", "doi": "10.1016/j.cis.2017.12.002", "journal": ["Advances in colloid and interface science", "Adv Colloid Interface Sci"], "date": "2018-01-18_23:42:09"}